Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association.
- DOI
- 10.1016/j.lanepe.2025.101408
- Published
- 2025 Oct
- Container
- The Lancet regional health. Europe
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2025.101408,
title = {Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association.},
author = {Allaire M and Da Fonseca LG and Sanduzzi-Zamparelli M and Choi WM and Monge C and Liu K and Leibfried M and Manes S and Maravic Z and Mishkovikj M and Bruix J and Reeves HL and Salem R and Sangro B},
year = {2025},
journal = {The Lancet regional health. Europe},
doi = {10.1016/j.lanepe.2025.101408},
url = {https://doi.org/10.1016/j.lanepe.2025.101408}
}RIS
TY - JOUR TI - Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association. AU - Allaire M AU - Da Fonseca LG AU - Sanduzzi-Zamparelli M AU - Choi WM AU - Monge C AU - Liu K AU - Leibfried M AU - Manes S AU - Maravic Z AU - Mishkovikj M AU - Bruix J AU - Reeves HL AU - Salem R AU - Sangro B PY - 2025 JO - The Lancet regional health. Europe DO - 10.1016/j.lanepe.2025.101408 UR - https://doi.org/10.1016/j.lanepe.2025.101408 ER -
APA
M, A., LG, D. F., M, S., WM, C., C, M., K, L., M, L., S, M., Z, M., M, M., J, B., HL, R., R, S., & B, S. (2025). Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101408
Source records
- pubmed · retrieved 2026-09-26T11:26:25.828Z